Veterinary teams enhance feline diabetes management through personalized care, effective communication, and evolving treatment options for improved quality of life.

As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

California Gov. Gavin Newsom listens media questions after announcing CaIRx-branded insulin glargine pens available next Jan.

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

In other news, Lilly announced its investigational oral GLP-1 agent orforglipron outperformed dapagliflozin (Farxiga) for ...

The state’s insulin — sold under the brand name CalRx — will be available at a recommended price of $11 per pen, or $55 for a ...

AI tools designed to make health care more efficient are ubiquitous, though many remain piecemeal and siloed, as researchers ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, on Friday announced the expansion of its strategic collaboration with Civica, Inc. to include a ...